| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,375,000 | 13,196,000 | 12,249,000 | 14,499,000 | | Cost of Revenue | 9,836,000 | 9,601,000 | 9,107,000 | 10,557,000 | | | Gross Profit | 3,539,000 | 3,595,000 | 3,142,000 | 3,942,000 | | | Operating Expenses | | Research Development | 344,000 | 384,000 | 409,000 | 490,000 | | Selling General and Administrative | 1,424,000 | 1,574,000 | 1,483,000 | 1,649,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,771,000 | 1,637,000 | 1,250,000 | 1,803,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,771,000 | 1,637,000 | 1,250,000 | 1,803,000 | | Interest Expense | 170,000 | 177,000 | 175,000 | 171,000 | | Income Before Tax | 1,601,000 | 1,460,000 | 1,075,000 | 1,632,000 | | Income Tax Expense | 456,000 | 394,000 | 276,000 | 403,000 | | Minority Interest | (87,000) | (167,000) |
-
| (84,000) | | | | Net Income From Continuing Ops | 1,058,000 | 899,000 | 799,000 | 1,145,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,058,000 | 899,000 | 799,000 | 1,145,000 | | Preferred Stock And Other Adjustments |
-
| 77,000 | (77,000) |
-
| | | Net Income Applicable To Common Shares | $1,058,000 | $976,000 | $722,000 | $1,145,000 |
|
0.16% Nasdaq 
Income Statement
